Verified earnings results

Latigo Biotherapeutics Q3 2026 Earnings Results

Direct answer

Latigo Biotherapeutics reported Q3 2026 results on November 5, 2026.

Revenue was 0. EPS beat the estimate by 12.56%.
The result is verified against Verified earnings source.
Verified earnings source

Get free Latigo Biotherapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Earnings date
November 5, 2026
Reported timing
Before the US market opens
EPS estimate
-0.629
Reported EPS
-0.55
Revenue
0
EPS surprise
EPS beat the estimate by 12.56%.

Read the frequently asked questions.

When did Latigo Biotherapeutics report Q3 2026 earnings?

Latigo Biotherapeutics reported on November 5, 2026. The reported timing was before the us market opens.

What is the available EPS estimate for Latigo Biotherapeutics?

The verified record provides an EPS estimate of -0.629.

Has Latigo Biotherapeutics reported the Q3 2026 result?

Revenue was 0. EPS beat the estimate by 12.56%.

Which source supports this Latigo Biotherapeutics earnings record?

The earnings record identifies Verified earnings source as its source. Missing values are not estimated.